Blog
RSS FeedPosted by Michael Wonder on 18 Jun 2019
Advisory Council supports biosimilars in call for universal public drug coverage in Canada
17 June 2019 - A Canadian advisory council is recommending the use of biosimilars in a final report that lays ...
Posted by Michael Wonder on 16 Jun 2019
Government crackdown on abuse of antibiotics
17 June 2019 - Doctors could be prevented from prescribing repeats of antibiotics as authorities consider radical plans to contain ...
Posted by Michael Wonder on 13 Jun 2019
Realigning incentives to optimise generic and biosimilar prescribing
13 June 2019 - Drug prices and their impact on total US health care expenditures are again front of mind ...
Posted by Michael Wonder on 11 Jun 2019
Systematic literature review calls economic impact of switching to biosimilars "uncertain"
10 June 2019 - Biosimilar drugs are intended by their developers to provide a cost-saving alternative to brand-name biologics, and ...
Posted by Michael Wonder on 06 Jun 2019
Patients, physicians raise concerns with BC biosimilar non-medical switching policy
6 June 2019 - On 27 May, the Government of British Columbia announced a policy that will forcibly switch thousands ...
Posted by Michael Wonder on 05 Jun 2019
NHS publishes update on the use of biosimilars
5 June 2019 - The United Kingdom’s National Health Service (NHS) has published a new document for clinical and nonclinical ...
Posted by Michael Wonder on 04 Jun 2019
PBM launches oncology biosimilar medical pharmacy initiative
4 June 2019 - Ahead of the anticipated 2019 marketing of FDA-approved anticancer biosimilars in the United States, pharmacy benefit manager ...
Posted by Michael Wonder on 04 Jun 2019
Biosimilar uptake drivers - etanercept
3 June 2019 - Information about Government initiatives to encourage the use of biosimilars is now available on the PBS website. ...
Posted by Michael Wonder on 20 May 2019
PBS Pharmaceuticals in Hospitals Review
20 May 2019 - The Department of Health completed the PBS Pharmaceuticals in Hospitals Review to better understand how PBS medicines ...
Posted by Michael Wonder on 13 May 2019
Australia's GBMA launches hub for biosimilar education
13 May 2019 - In 2018, the Generic Biosimilar Medicines Association was awarded the Biosimilar Education Grant by the Australian government ...
Posted by Michael Wonder on 14 Apr 2019
Biopharma CEOs explain problems with biosimilars to Congress
12 April 2019 - Following their Senate Finance Committee hearing in February, all seven biopharmaceutical CEOs have now offered hundreds ...
Posted by Michael Wonder on 03 Apr 2019
Overprescribed: high cost isn’t America’s only drug problem
2 April 2019 - The pharmaceutical industry has followed a brilliant two-pronged strategy to maximize its profits: raise prices and ...
Posted by Michael Wonder on 25 Mar 2019
19,000 Australians now using PBS subsidised anti-HIV drugs
25 March 2019 - About 19,000 Australians have taken advantage of anti-HIV drugs in the first two years of groundbreaking ...
Posted by Michael Wonder on 23 Mar 2019
Lyrica, Pfizer, and how big pharma gets what it wants
23 March 2019 - In 2011, few had heard of Pfizer’s nerve-pain pill Lyrica. It was mostly confined to specialist ...
Posted by Michael Wonder on 21 Mar 2019
Promoting biosimilars up to health plans, manufacturers, doctors, Gottlieb says
21 March 2019 - As he wraps up his final weeks as commissioner of the FDA, Scott Gottlieb, MD, talked about ...